News Image

Molecular Partners to Present at Upcoming Investor Conferences

Provided By GlobeNewswire

Last update: May 19, 2025

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced that members of the management team will participate in two upcoming investor conferences.

Read more at globenewswire.com

MOLECULAR PARTNERS AG -ADR

NASDAQ:MOLN (7/25/2025, 8:07:47 PM)

After market: 3.6 -0.27 (-6.94%)

3.8685

-0.13 (-3.29%)



Find more stocks in the Stock Screener

Follow ChartMill for more